JP2009507851A5 - - Google Patents

Download PDF

Info

Publication number
JP2009507851A5
JP2009507851A5 JP2008530198A JP2008530198A JP2009507851A5 JP 2009507851 A5 JP2009507851 A5 JP 2009507851A5 JP 2008530198 A JP2008530198 A JP 2008530198A JP 2008530198 A JP2008530198 A JP 2008530198A JP 2009507851 A5 JP2009507851 A5 JP 2009507851A5
Authority
JP
Japan
Prior art keywords
ring
optionally substituted
compound
aliphatic
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008530198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009507851A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/034857 external-priority patent/WO2007030618A2/en
Publication of JP2009507851A publication Critical patent/JP2009507851A/ja
Publication of JP2009507851A5 publication Critical patent/JP2009507851A5/ja
Pending legal-status Critical Current

Links

JP2008530198A 2005-09-09 2006-09-08 電位型イオンチャネルの調節因子としての二環式誘導体 Pending JP2009507851A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71598005P 2005-09-09 2005-09-09
PCT/US2006/034857 WO2007030618A2 (en) 2005-09-09 2006-09-08 Bicyclic derivatives as modulators of voltage gated ion channels

Publications (2)

Publication Number Publication Date
JP2009507851A JP2009507851A (ja) 2009-02-26
JP2009507851A5 true JP2009507851A5 (https=) 2009-10-15

Family

ID=37686027

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008530198A Pending JP2009507851A (ja) 2005-09-09 2006-09-08 電位型イオンチャネルの調節因子としての二環式誘導体

Country Status (14)

Country Link
US (4) US7855220B2 (https=)
EP (1) EP1928871A2 (https=)
JP (1) JP2009507851A (https=)
KR (1) KR20080044910A (https=)
CN (1) CN101300253B (https=)
AU (1) AU2006287480B2 (https=)
CA (1) CA2622076A1 (https=)
IL (1) IL190017A0 (https=)
MX (1) MX2008003337A (https=)
NO (1) NO20081725L (https=)
NZ (1) NZ567132A (https=)
RU (1) RU2008113836A (https=)
WO (1) WO2007030618A2 (https=)
ZA (1) ZA200802977B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491827B2 (en) * 2002-12-23 2009-02-17 Millennium Pharmaceuticals, Inc. Aryl sulfonamides useful as inhibitors of chemokine receptor activity
US7615563B2 (en) * 2003-08-08 2009-11-10 Gonzalez Iii Jesus E Compositions useful as inhibitors of voltage-gated sodium channels
MX2007014180A (es) * 2005-05-10 2008-01-14 Vertex Pharma Derivados biciclicos como moduladores de canales de iones.
CA2608599A1 (en) * 2005-05-16 2006-11-23 Vertex Pharmaceuticals Incorporated Bicyclic derivatives as modulators of ion channels
MX2008003337A (es) * 2005-09-09 2008-09-26 Vertex Pharma Derivados biciclicos como modulares de canales ionicos regulados por voltaje.
CN101331115A (zh) * 2005-10-21 2008-12-24 沃泰克斯药物股份有限公司 调控离子通道的衍生物
EP2316829A1 (en) * 2005-12-21 2011-05-04 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives as modulators of ion channels
MX2009012678A (es) 2007-05-25 2012-09-20 Vertex Pharma Moduladores de canal de ion y metodos de uso.
US7994174B2 (en) * 2007-09-19 2011-08-09 Vertex Pharmaceuticals Incorporated Pyridyl sulfonamides as modulators of ion channels
WO2009064752A2 (en) * 2007-11-13 2009-05-22 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives as modulators of ion channels
US7994166B2 (en) * 2007-11-13 2011-08-09 Vertex Pharmaceuticals Incorporated Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of pain
WO2009133641A1 (ja) * 2008-04-30 2009-11-05 シャープ株式会社 照明装置、及び表示装置
WO2010002956A2 (en) * 2008-07-01 2010-01-07 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives as modulators of ion channels
PE20110164A1 (es) * 2008-07-02 2011-03-28 Hoffmann La Roche Nuevas fenilpirazinonas como inhibidores de quinasa
JP2011530512A (ja) * 2008-08-06 2011-12-22 メルク・シャープ・エンド・ドーム・コーポレイション カルシウムチャネル遮断薬としての置換ジヒドロイソキノリノン及びイソキノリンジオン誘導体
RS56015B1 (sr) 2013-01-31 2017-09-29 Vertex Pharma Piridon amidi kao modulatori natrijumovih kanala
CA3105657A1 (en) 2018-07-09 2020-01-16 Lieber Institute, Inc. Pyridine carboxamide compounds for inhibiting nav1.8
AU2019302534B2 (en) 2018-07-09 2024-10-03 Lieber Institute, Inc. Pyridazine compounds for inhibiting NaV1.8
EP4079724B1 (en) * 2019-12-30 2025-11-12 Wuhan LL Science and Technology Development Co., Ltd. 2-(2-chlorophenyl)-n-(5-sulfamoylisoquinolin-7-yl)acetamide derivatives and similar compounds as p2x4 antagonists for the treatment of e.g. urinary tract diseases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378715A (en) * 1992-02-24 1995-01-03 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
TWI234557B (en) 1999-05-26 2005-06-21 Telik Inc Novel naphthalene ureas as glucose uptake enhancers
JP2003055209A (ja) * 2001-07-31 2003-02-26 Bayer Ag フェニルナフチル尿素誘導体
WO2003097586A1 (en) * 2002-05-17 2003-11-27 Janssen Pharmaceutica N.V. Aminotetralin-derived urea modulators of vanilloid vr1 receptor
US7491827B2 (en) * 2002-12-23 2009-02-17 Millennium Pharmaceuticals, Inc. Aryl sulfonamides useful as inhibitors of chemokine receptor activity
EP1673357A2 (en) 2003-08-08 2006-06-28 Vertex Pharmaceuticals Incorporated Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
US7615563B2 (en) * 2003-08-08 2009-11-10 Gonzalez Iii Jesus E Compositions useful as inhibitors of voltage-gated sodium channels
MX2007014180A (es) * 2005-05-10 2008-01-14 Vertex Pharma Derivados biciclicos como moduladores de canales de iones.
CA2608599A1 (en) * 2005-05-16 2006-11-23 Vertex Pharmaceuticals Incorporated Bicyclic derivatives as modulators of ion channels
MX2007015726A (es) * 2005-06-09 2008-03-04 Vertex Pharma Derivados de indano como moduladores de canales ionicos.
MX2008003337A (es) 2005-09-09 2008-09-26 Vertex Pharma Derivados biciclicos como modulares de canales ionicos regulados por voltaje.
EP1934191B1 (en) 2005-10-12 2012-03-28 Vertex Pharmaceuticals, Inc. Biphenyl derivatives as modulators of voltage gated ion channels
CN101331115A (zh) * 2005-10-21 2008-12-24 沃泰克斯药物股份有限公司 调控离子通道的衍生物
EP2316829A1 (en) * 2005-12-21 2011-05-04 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives as modulators of ion channels
US8293450B2 (en) * 2006-11-28 2012-10-23 Hewlett-Packard Development Company, L.P. Laser imaging coating and methods for imaging
MX2009012678A (es) 2007-05-25 2012-09-20 Vertex Pharma Moduladores de canal de ion y metodos de uso.
US7994174B2 (en) * 2007-09-19 2011-08-09 Vertex Pharmaceuticals Incorporated Pyridyl sulfonamides as modulators of ion channels
WO2009064752A2 (en) 2007-11-13 2009-05-22 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives as modulators of ion channels
US7994166B2 (en) * 2007-11-13 2011-08-09 Vertex Pharmaceuticals Incorporated Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of pain
WO2010002956A2 (en) 2008-07-01 2010-01-07 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives as modulators of ion channels

Similar Documents

Publication Publication Date Title
JP2009507851A5 (https=)
JP2009511599A5 (https=)
JP2008543785A5 (https=)
CA2829117C (en) Novel 6-arylamino pyridone carboxamide as mek inhibitors
JP2008540661A5 (https=)
CA2651375C (en) Treatment of cell proliferative disorders
CN111801339B (zh) 5-氟尿嘧啶化合物
JP2019523228A (ja) カンナビノイドプロドラッグの製造のための方法、薬学的製剤、およびその使用
RU2007145434A (ru) Бициклические производные в качестве модуляторов ионных каналов
KR20160013072A (ko) 안드로겐 수용체 조절제의 에스터 유도체 및 그의 이용 방법
RU2007148504A (ru) Индановые производные в качестве модуляторов ионных каналов
RU2008118350A (ru) Бифенильные производные в качестве модуляторов потенциалзависимых ионных каналов
EP3052500A1 (fr) Inhibiteurs de 5'-nucléotidases et leurs utilisations thérapeutiques
US7608615B2 (en) Pyrrolo[2,1-C][1,4]benzodiazepine hybrids and a process for the preparation thereof
RU2008113836A (ru) Бициклические производные в качестве модуляторов потенциалозависимых ионных каналов
JP7399171B2 (ja) 腎疾患に対するシュウ酸カルシウム結晶化阻害剤
AU2019452636B2 (en) Thienopyrimidine derivatives having stereo configurations and use thereof in medicine
HK1210432A1 (en) Doxorubicin adjuvants to reduce toxicity and methods for using the same
WO2018084321A1 (ja) Ｅｇｆｒ阻害及び腫瘍治療に有用な新規化合物
JP2007532628A5 (https=)
JP2008540666A5 (https=)
JPH07500115A (ja) 抗腫瘍活性を高めるための複素環化合物
TWI638825B (zh) 抑制癌症及病毒之化合物
CN110248950A (zh) 作为异羟肟酸的前体药的化合物或其盐、冷冻干燥制剂、LpxC抑制剂及抗菌剂
CN110049973B (zh) 1,4-二苯基-1h-咪唑和2，4-二苯基噻唑类衍生物及其制备方法和用途